Holding(s) In Company
On October 20, 2025, Acme Investments SPF Sarl, fully owned by Timo Syrjälä, crossed a threshold requiring notification of major holdings in Faron Pharmaceuticals Ltd. The total number of voting rights held is 17,225,396, representing 15.18% of voting rights attached to shares. This is an increase from the previous notification of 16,918,396 voting rights, which represented 15.00% (14.997%) of voting rights. Timo Syrjälä directly holds 4.67% of the voting rights, while Acme Investments SPF Sarl indirectly holds 10.51%. The change is due to a private placement.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
| Faron Pharmaceuticals Ltd | Company announcement | October 21, 2025 at 16:10:00 EEST |
TR-1: Standard form for notification of major holdings
- Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
| Non-UK issuer | X |
- Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights
| An acquisition or disposal of financial instruments | X |
An event changing the breakdown of voting rights
Other (please specify) iii : Change due the Private Placement
Details of person subject to the notification obligation iv
| Name | Timo Syrjälä |
| City and country of registered office (if applicable) | Monaco |
Full name of shareholder(s) (if different from 3.) v
| Name | Acme Investments SPF Sarl |
|---|---|
| City and country of registered office (if applicable) | Luxembourg |
| 5. Date on which the threshold was crossed or reached vi : | 20.10.2025 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 20.10.2025 |
- Total positions of person(s) subject to the notification obligation
| Name | Acme Investments SPF Sarl | |||
|---|---|---|---|---|
| City and country of registered office (if applicable) | Luxembourg | |||
| Resulting situation on the date on which threshold was crossed or reached | 15,18 | 17.225.396 | ||
| Position of previous notification (if applicable) | 15,00 (14,997%) | 16.918.396 | ||
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | |
| FI4000153309 | 5.296.452 | 11.928.944 | 4,67% | 10,51% |
| SUBTOTAL 8. A | 17.225.396 | 15,18% | ||
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
| Timo Syrjälä (Direct) | 4,67% | 4,67% |
| Acme Investments SPF Sarl (Indirect) | 10,51% | 10,51% |
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
Acme Investment SPF Sarl is fully owned by Timo Syrjälä
| Place of completion | Monaco |
|---|---|
| Date of completion | 20.10.2025 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.